Preview Mode Links will not work in preview mode

Nov 16, 2022

Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in melanoma. Featuring perspectives from Prof Georgina Long, including the following topics:

  • Neoadjuvant and Adjuvant Therapy for Melanoma (0:00)
  • Update on the Management of...

Oct 27, 2022

Featuring a slide presentation and related discussion from Prof Axel Hauschild, including the following topics:

  • Emerging data with targeted agents for metastatic melanoma (0:00)
  • Current and future roles for immune checkpoint inhibitors in therapy for melanoma (11:13)
  • Comparing targeted agents and immune checkpoint...

Oct 27, 2022

Featuring an interview with Prof Axel Hauschild, including the following topics:

  • Pan-tumor approval of dabrafenib/trametinib; data with adjuvant targeted therapy for melanoma (0:00)
  • Emerging data with encorafenib/binimetinib for Stage II melanoma; switching from dabrafenib/trametinib...

Mar 16, 2022

The Great Adjuvant Debate — Exploring the Role of Novel Therapies in the Management of Localized Cancer — Faculty Presentation 1: Selection of Adjuvant Systemic Therapy for High-Risk Melanoma — Dr Jeffrey Weber

CME information and select...

Jan 18, 2022

Featuring perspectives from Dr Jason Luke, including the following topics: 

  • Introduction (0:00)
  • DREAMseq Phase III Study (3:03)
  • Case: A woman in her mid-50s with metastatic melanoma and a BRAF V600K mutation — Evan J Lipson, MD (18:08)
  • Case: A man in his mid-60s with metastatic melanoma and a BRAF V600E mutation —...